HoyaHOCPY +0.82%98 Net Current Asset Value is $12.78 as of Mar. 2026, which is 28% above its 10-year median of 10.01. GuruFocus rates HOCPY with a GF Score™ of 98/100 and a GF Value™ of $152.70 (Fairly Valued). The stock has 1 warning sign investors should review. Among 569 Medical Devices & Instruments companies, Hoya ranks worse than 77.15% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Hoya's net current asset value per share for the quarter that ended in Mar. 2026 was $12.78.
The historical rank and industry rank for Hoya's Net Current Asset Value or its related term are showing as below:
HOCPY'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6 Med: 10.01 Max: 13.09
Current: 12.31
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Hoya was 13.09. The lowest was 6.00. And the median was 10.01.
HOCPY's Price-to-Net-Current-Asset-Value is ranked worse than 77.15% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 4.99
vs HOCPY: 12.31
Hoya (OTCPK:HOCPY) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Hoya Net Current Asset Value Related Terms
Hoya Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Hoya's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HOCPY vs ISRG, BDX, MDLN: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Hoya's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoya Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hoya's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Hoya's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $12.78 mean?
Hoya (HOCPY) has a Net Current Asset Value of $12.78 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Hoya and its competitors. This is 28% above median its historical median of 10.01. Over the past decade, Hoya's Net Current Asset Value has ranged from 6.00 to 13.09. According to the industry distribution chart, Hoya ranks #439 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 77.2%.
Is Hoya's Net Current Asset Value too high?
Hoya's current Net Current Asset Value of $12.78 is 28% above median its 10-year median of 10.01. Over the past 10 years, this metric has ranged from a low of 6.00 to a high of 13.09. The Medical Devices & Instruments industry median Net Current Asset Value is 4.99. Hoya's value of $12.78 is 156.1% above this industry median. Based on the distribution chart, Hoya ranks #439 out of 569 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Hoya has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hoya's Net Current Asset Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hoya ranks #439 out of 569 companies for Net Current Asset Value. This places Hoya in the lower half of its industry. The industry median Net Current Asset Value is 4.99. Hoya's value of $12.78 is 156.1% above this benchmark. Historically, Hoya's own Net Current Asset Value has ranged from 6.00 to 13.09 over the past decade. While the company's 10-year median is 10.01 vs. the industry median of 4.99, Hoya has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoya's current Net Current Asset Value of $12.78 is 156.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Hoya and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoya's current Net Current Asset Value is $12.78, which is 28% above median its own 10-year median of 10.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoya stock overvalued right now?
Based on GuruFocus' analysis, Hoya (HOCPY) is currently considered Fairly Valued. The stock's GF Value™ is $152.70, compared to a current price of $155.72 — trading 2% above its estimated fair value. The current Net Current Asset Value is $12.78, which is 28% above median its 10-year median of 10.01 and 156.1% above the Medical Devices & Instruments industry median of 4.99. Hoya's overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Hoya (HOCPY), the current Net Current Asset Value is $12.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoya (HOCPY) Overvalued in 2026?
Based on GuruFocus' analysis, Hoya stock appears to be overvalued.
The current stock price of $155.72 is trading 2% above its estimated GF Value™ of $152.70.
GuruFocus considers Hoya to be Fairly Valued.
Key valuation signals for HOCPY:
Net Current Asset Value: $12.78 (28% above median its 10-year median of 10.01)
GF Value™: $152.70 vs. price of $155.72 (2% above fair value)
Industry Position: 156.1% above the Medical Devices & Instruments median (#439 of 569)
No single metric tells the full story. See the HOCPY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 1941 in Tokyo as an optical glass production plant, Hoya is one of the largest eyeglass lens manufacturers in the world. Leveraging its technology know-how in glass manufacturing, Hoya entered the mask blanks business in 1974. Now although its life care business accounts for more than 60% of its total revenue, majority of its profit before tax comes from its higher-margin IT business.
98GF Score
Get the complete analysis for HOCPY
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HOCPY has been successfully added to your 
